A phase I study of dasatinib with concurrent chemoradiation for stage III non small cell lung cancer (NSCLC)

by Howard eSafran, Thomas eDiPetrillo, Humera eKhurshid, Thomas eNg, Kalyan eMantripragada, Ariel eBirnbaum, David eBerz, Kathy eRadie-Keane, Kimberly ePerez, Maria eConstantinou, Denise eLuppe, Andrew eSchumacher, Kara eLeonard
Published 2012-05-01